Merck MRK announced that the FDA has granted the Breakthrough Therapy designation (BTD) to its B7-H3-directed DXd ...

An executive cites the company's 140-year track record as it faces federal action on drug pricing and industry tariffs.

BBIO's Acoramidis shows promise but faces tough competition. Diverse pipeline & catalysts ahead, but valuation relies on ...

With Trump's backing, the pharma industry is leaning into the idea of more "direct-to-consumer" sales. But experts say the ...

President Trump wrote to major drug companies, informing them that they had to comply with his “Most Favored Nation” order.

The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech?

A declining stock price amid steadily rising payouts means Realty Income stock offers an above-average yield of 5.5% at ...

Pfizer set about evaluating inclacumab in pair of phase 3 studies, dubbed Thrive. The Big Pharma terminated one of those ...

Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives ...

The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.

Discover key highlights in healthcare stocks, including UnitedHealth's surge after a Buffett stake, Eli Lilly lawsuits, Trump pharma tariffs & Bayer's ...

The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?